*** SCHEDULE & PROGRAM ***
( updated on September 4 th, 2007 )
Please note that this program may be changed at any time by the organizers.
|
Sunday, October 21 st, 2007 |
4:00-7:00 pm Registration and Poster setup
7:00-7:30 pm Opening Remarks - Annick Pierce, Piera Valenti & Dominique Legrand
7:30-9:30 pm Welcome Evening Buffet
|
Monday, October 22 nd, 2007 |
|
Session I - Lactoferrin : structure-function relationships (9:00-10:10am) |
Chair Persons : J. Mazurier – H. Vogel
9:00-9:30 am Edward N. Baker (Auckland, New Zealand)
"A structural overview of lactoferrin function - twenty years on"
9:30-9:50 am Celia Conesa (Zaragoza, Spain)
"Investigation of the interaction of human lactoferrin with human ceruloplasmin"
9:50-10:10 am Vadim Vasilyev (Saint-Petersburg, Russia)
"Complexes of ceruloplasmin with lactoferrin and myeloperoxidase as an index of neutrophil activity"
|
10:10-10:40 am Coffee Break - Posters |
|
Session II - Lactoferrin expression and regulation (10:40-12:30pm) |
Chair Persons : E. Baker – B. Lönnerdal
10:40-11:10 am Christina Teng (Research Triangle Park, NC, USA)
"Mechanism of LPS induction on lactoferrin expression in mammary gland cells"
11:10-11:30 am Antonella Baldi (Milan, Italy)
"Effect of lipopolysaccharides on bovine lactoferrin mRNA expression by mammary epithelial cells in vitro"
11:30-11:50 am Chiara Pecorini (Milan, Italy)
"Lactoferrin is localized at the two sides of the mouse mammary epithelium"
11:50-12:10 pm Fiona O'Halloran (Fermoy, Cork, Ireland)
"Molecular and functional investigation of lactoferrin variants isolated from different cattle breeds"
12:10-12:30 pm Ivan Sheiko (Zhodino, Belarus)
"Production of transgenic goats with human lactoferrin"
| 1:00-3:00 pm Lunch time |
|
Session II - Lactoferrin expression and regulation (continued) (3:00-3:40pm) |
Chair Persons : E. Baker – B. Lönnerdal
3:00-3:20 pm Ashoka Sreedhara (Aas, Norway)
"Changes in the contents of goat milk lactoferrin and lactoperoxidase in relation to the genetic variants of alpha s1-casein"
3:20-3:40 pm Hélène Soyeurt (Gembloux, Belgium)
"Variability of lactoferrin content predicted by mid-infrared spectrometry in bovine milk"
|
Session III - Lactoferrin receptors (3:50-5:00pm) |
Chair Persons : C. Teng – D. Legrand
3:50-4:20 pm Bo Lönnerdal (Davis, TX, USA)
"Receptor-mediated endocytosis of lactoferrin "
4:20-4:40 pm Maryam Amini (London, England, UK)
"A study of human lactoferrin and transferrin interactions with their respective bacterial receptors, LbpA and TbpA, from Neisseria meningitidis"
4:40-5:00 pm Anthony Schryvers (Calgary, Alberta, Canada)
"Lactoferrin binding protein B mediates resistance to the antimicrobial activity of lactoferricin"
|
5:00-5:30 pm Coffee Break - Posters |
|
Session IV - Lactoferrin immuno-modulatory and anti-inflammatory properties (5:30-7:20pm) |
Chair Persons : J. Cornish – D. Legrand
5:30-6:00 pm Jeremy Brock (Glasgow, Scotland, UK)
"Lactoferrin in immunity and inflammation - an overview"
6:00-6:20 pm Sandra Gessani (Rome, Italy)
"Immunomodulatory effects of bovine lactoferrin in human myeloid dendritic cells"
6:20-6:40 pm Shen-An Hwang (Houston, TX, USA)
"Lactoferrin enhances the BCG vaccine by promoting T-cell activation through modulation of dendritic cell presentation molecules"
6:40-7:00 pm Koji Yamauchi (Zama, Japan)
"Hepatoprotective effect of oral bovine lactoferrin on D-galactosamine-induced hepatitis in mice: comparison with other whey proteins"
7:00-7:20 pm Saori Kobayashi (Iwate, Japan)
"Oral therapy with bovine lactoferrin in dogs with congenital neutrophil dysfunction"
|
Tuesday, October 23 rd, 2007 |
|
Session V - Regulation of cell cycle and apoptosis by lactoferrin (9:00-10:30am) |
Chair Persons : J. Brock – A. Pierce
9:00-9:30 am Sang-Yun Choi (Seoul, Korea)
"Regulation of cell proliferation and apoptosis by human lactoferrin"
9:30-9:50 am Christophe Mariller (Villeneuve d'Ascq, France)
"Delta-lactoferrin is a transcription factor regulating cell progression and survival"
9:50-10:10 am Stefan Imreh (Stockholm, Sweden)
"Lactoferrin: one of the tumor suppressor genes at 3p21.3"
10:10-10:30 am Thorgunnur Petursdottir (Reykjavik, Iceland)
"Loss of the lactotransferrin gene is frequent in human solid tumors and the A29T polymorphism is common in lung cancer patients"
|
10:30-11:00 am Coffee Break - Posters |
|
Session V - Regulation of cell cycle and apoptosis by lactoferrin (continued) (11:00-12:10pm) |
Chair Persons : J. Brock – A. Pierce
11:00-11:30 am Hiroyuki Tsuda (Nagoya, Japan)
"Cancer prevention by bovine lactoferrin – From animal studies to human trials"
11:30-11:50 am Anca Roseanu (Bucharest, Roumania)
"Effect of free and liposome-entrapped lactoferrin on murine and human melanoma cells"
11:50-12:10 pm David Alexander (Nagoya, Japan)
"A lactoferrin expressing, helper adenovirus-dependent vector: construction and initial observations"
|
12:30-3:00 pm Lunch time |
|
Session VI - Growth-promoting activity of lactoferrin (3:00-4:50pm) |
Chair Persons : S. Choi - K. Shimazaki
3:00-3:30 pm Jillian Cornish (Auckland, New Zealand)
"Lactoferrin, a regulator of bone growth"
3:30-3:50 pm Anne Blais (Paris, France)
"Dietary bovine lactoferrin improves the bone status of ovariectomized mice"
3:50-4:10 pm Yoshiharu Takayama (Tsukuba, Japan)
"Modulated release of bovine lactoferrin from collagen membrane and application for bone tissue engineering"
4:10-4:30 pm Ushasree Pattamatta (Sydney, Australia)
"Bovine lactoferrin stimulates human corneal epithelial wound healing in vitro"
4:30-4:50 pm Yasushi Suzuki (Kashiwara, Japan)
"Bovine lactoferrin promotes wound healing in diabetic mice"
|
4:50-5:20 pm Coffee Break - Posters |
|
Session VII - Antimicrobial activity of lactoferrin (5:20-6:50pm) |
Chair Persons : D. Fine - A. Schryvers
5:20-5:50 pm Kei-ichi Shimazaki (Sapporo, Japan)
"Offensive and defensive activities of lactoferrin against microorganisms"
5:50-6:10 pm Mark Willcox (Sydney, Australia)
"Lactoferrin acts in conjunction with other antimicrobials and controls growth of Staphylococcus epidermidis"
6:10-6:30 pm Franscesca Berlutti (Avellino, Italy)
"Could lactoferrin be useful to counteract Burkholderia cenocepacia lung infection in cystic fibrosis patients ?"
6:30-6:50 pm Hiroyuki Wakabayashi (Zama, Japan)
"Antimicrobial activity of lactoferrin against periodontal pathogens and its application to periodontitis patients"
8:00-10:00 pm Wine and Cheese Party - Poster Sessions
|
Wednesday, October 24 th, 2007 |
|
Session VIII - Antimicrobial activity of lactoferrin-derived peptides (9:00-10:30am) |
Chair Persons : P. Valenti - H. Vogel
9:00-9:30 am Hans Vogel (Calgary, Alberta, Canada)
"Lactoferrin, bioactive host-defense peptides and their interactions"
9:30-9:50 am Masako Umeyama (Yokohama, Japan)
"Interaction of bovine lactoferricin with acidic phospholipid bilayers and elucidation of its antimicrobial activity as studied by solid-state NMR spectroscopy"
9:50-10:10 am Marjolaine Arseneault (Laval, Québec, Canada)
"Interaction of Lactoferricin B with membranes: a physico-chemical approach"
10:10-10:30 am Jan Bolscher (Amsterdam, The Netherlands)
"Chimerization of the two bovine lactoferrin peptides, lactoferricin and lactoferrampin, strongly potentiates their antimicrobial activity: biological and biophysical implications"
|
10:30-11:00 am Coffee Break - Posters |
|
Session VIII - Antimicrobial activity of lactoferrin-derived peptides (continued) (11:00-12:10pm) |
Chair Persons : P. Valenti - H. Vogel
11:00-11:30 am Jian-Hua Wang (Beijing, China)
"Design and heterologous expression of novel lactoferrin derived-peptides with anti-microbial activity"
11:30-11:50 am Anne Van Der Does (Leiden, The Netherlands)
"The antimicrobial peptide hLF1-11 enhances recognition and elimination of pathogens by macrophages"
11:50-12:10 pm Nidia Leon-Sicairios (Culiacan, Mexico)
"Bactericidal activity of bovine lactoferrin, LFampin, LFcin and Chimeric peptide (LFcin-LFampin) against Vibrio parahaemolyticus"
|
12:30-2:00 pm Lunch time |
Sponsor Meeting - Jean-Paul Perraudin (Les Isnes, Belgium)
|
8:30 pm Gala Dinner |
|
Thursday, October 25 th, 2007 |
|
Session IX - Lactoferrin and applications in health / novel functions (9:00-10:30am) |
Chair Persons : J.-P. Perraudin - H. Tsuda
9:00-9:30 am Mamoru Tomita (Japan)
"Overview of recent advances of bovine lactoferrin researches for applications"
9:30-9:50 am Piera Valenti (Rome, Italy)
"Oral administration of lactoferrin in thrombophilic pregnant women suffering of iron deficiency and iron deficiency anaemia"
9:50-10:10 am Maki Sawada (Tokyo, Japan)
"Recombinant human lactoferrin suppresses premature cervical ripening"
10:10-10:30 am Theresa Ochoa (Lima, Peru)
"Randomized controlled pilot study of bovine lactoferrin for prevention of diarrhea in children"
|
10:30-11:00 am Coffee Break - Posters |
|
Session IX - Lactoferrin and applications in health / novel functions (continued) (11:00-12:40pm) |
Chair Persons : J.-P. Perraudin - H. Tsuda
11:00-11:20 am Elena Nemtsova (Moscow, Russia)
"Laprot - a unique detoxifying and anti-inflammatory preparation"
11:20-11:40 am Daniel Fine (Newark, NJ, USA)
"The identification of a Lactoferrin polymorphism associated with caries resistance"
11:40-12:00 pm Saichiro Yokoyama (Kagoshima, Japan)
"Responses in branchial heat shock protein 70 of scorpion fish Sebastiscus marmoratus fed dietary bovine lactoferrin"
12:00-12:20 pm Karrie Sanders (Geelong, Australia)
"A randomised clinical trial investigating lactoferrin supplements on health parameters of chronic diseases"
12:20-12:40 pm Louis Istasse (Liège, Belgium)
"Lactoferrin and lactoperoxidase system as oral supplements to newborn dairy calves"
|
12:40-1:00 pm Concluding remarks - Anthony Schryvers (Calgary, Alberta, Canada) |
|
1:00-3:00 pm Lunch time |